RSS-Feed abonnieren
DOI: 10.1055/s-2005-861402
Humorale Mukosa-Immunantwort bei der Rhinitis allergica
Humoral Mucosal Immunity in Allergic RhinitisPublikationsverlauf
Eingegangen: 22. Juni 2004
Angenommen: 10. Januar 2005
Publikationsdatum:
23. Mai 2005 (online)
![](https://www.thieme-connect.de/media/lro/200507/lookinside/thumbnails/10.1055-s-2005-861402-1.jpg)
Zusammenfassung
Hintergrund: Ziel der vorliegenden Arbeit war die Untersuchung allergen-spezifischer Immunglobuline (Ig) der Klassen IgA und IgG im Nasensekret als Ausdruck einer eigenständigen Mukosa-Immunantwort bei der Rhinitis allergica.
Methoden: Nasensekrete von 40 Allergikern wurden auf allergen-spezifisches IgA, IgG und IgE sowie auf ECP und Tryptase untersucht. 43 nicht-atopische Individuen dienten als Kontrolle. Um mögliche Einflüsse der aktuellen Pollenbelastung auf die untersuchten Parameter zu evaluieren, verglichen wir Pollinotiker co- (n = 28) versus extra-saisonal (n = 41). Weiterhin untersuchten wir 5 Patienten nach nasaler Allergenprovokation, um einen möglichen Einfluss des allergen-spezifischen IgA bei der Degranulation von Eosinophilen zu erfassen.
Ergebnisse: Im Vergleich zu den nicht-atopischen Kontrollen fanden wir signifikant erhöhte allergen-spezifische Ig aller untersuchten Klassen und Antigene bei den Allergikern. Co-saisonal fanden wir erhöhte Konzentrationen von allergen-spezifischem IgE, ECP und Tryptase, jedoch niedrigere Konzentrationen von allergen-spezifischem IgA und IgG. Es fand sich keine Assoziation zwischen der Eosinophilie in der allergischen Spätphase nach Provokation und dem allergen-spezifischen IgA.
Diskussion: Den Nachweis von allergen-spezifischem IgA und IgG im Nasensekret von Patienten mit allergischer Rhinitis interpretieren wir als Ausdruck einer eigenständigen, humoralen Mukosa-Immunantwort.
Abstract
Background: Mucosa-immunologic aspects are gaining an increasing awareness in the pathophysiology of type I allergies. Humoral mucosal immune responses are dominated by secretory IgA, but there is evidence for a relevant role of IgG in nasal mucosa-associated lymphoid tissue.
Objective: was to measure allergen-specific immunoglobulins (IgA and IgG) in nasal secretions as an expression of a humoral mucosal immune response in allergic rhinitis. For tissue eosinophilia we studied nasal Eosinophilic Cationic Protein (ECP) and for mast cell activation nasal tryptase.
Methods: Nasal secretions of 40 patients suffering from allergic rhinitis were analyzed for allergen-specific IgA, IgG, and IgE, and for ECP and tryptase. Patients were highly sensitized against the major allergens of house dust mites, timothy, and birch pollen. 43 non-atopic individuals served as controls. In order to study possible effects of the actual pollen season on the studied parameter we secondly compared patients allergic to seasonal allergens co- (n = 28) and extra-seasonally (n = 41). In order to determine a possible influence of allergen-specific IgA in eosinophilic degranulation we additionally studied 5 patients after nasal allergen challenge.
Results: In allergic rhinitis we found significantly increased levels of allergen-specific immunoglobulins of all studied subclasses and allergens in nasal secretions. Comparison of nasal ECP and tryptase showed significantly increased concentrations in allergic individuals as well. Co-seasonally we found elevated allergen-specific IgE, ECP, and tryptase but lower concentrations of allergen-specific IgA and IgG. There was no association between late phase eosinophilia and IgA concentrations after local allergen challenge.
Conclusions: The occurrence of allergen-specific immunoglobulins in nasal secretions is interpreted as a local humoral mucosal immune response. The physiologic role of local allergen-specific immunoglobulins is not clear to date. Involvement in degranulation of eosinophils or mast cells, like suggested before, seems unlikely.
Schlüsselwörter
allergische Rhinitis - Mukosa-Immunologie - MALT - allergen-spezifische Immunglobuline - Nasensekret
Key words
Allergic rhinitis - mucosal immunity - MALT - allergen-specific immunoglobulin - nasal secretions
Literatur
- 1 Wiedermann U, Jahn S B, Fritsch R. et al . Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen. Clin Exp Immunol. 1998; 111 144-151
- 2 Wiedermann U, Jahn S B, Repa A, Kraft D, Ebner C. Modulation of an allergic immune response via the mucosal route in a murine model of inhalative type-I allergy. Int Arch Allergy Immunol. 1999; 118 129-132
- 3 Wiedermann U, Jahn S B, Bohle B. et al . Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant Bet v1, the major birch pollen antigen, in a murine model of type I allergy. J Allergy Clin Immunol. 1999; 103 1202-1210
- 4 Weiner H L. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today. 1997; 18 335-342
- 5 Xiao B G, Link H. Mucosal tolerance: a two edged sword to prevent and treat autoimmune diseases. Clin Immunol Immunopathol. 1997; 85 119-128
- 6 Holt B J, Batty J E, Turner K G. Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology. 1981; 42 409-417
- 7 McMenamin C, Pimm C, McKersey M, Holt P. Regulation of IgE responses to inhaled antigen in mice by antigen-specific gd T cells. Science. 1994; 265 1869-1871
- 8 Hoyne G, Askonas B A, Hetzel C, Thomas W R, Lamb J R. Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cell responses precedes the development of tolerance in vivo. Int Immunol. 1996; 7 335-342
- 9 Gebert A, Werner K, Fassbender S, Kramer M F. Immunhistochemischer Nachweis von M-Zellen in der Tonsilla palatina des Menschen - Charakterisierung eines besonderen intraepithelialen Kompartiments. Ann Anat. 2000; 182 130 (Abstrakt)
- 10 Gebert A, Fassbender S, Kramer M F. M-Zellen der Tonsilla palatina des Menschen besitzen die notwendigen Moleküle zur Initiierung von Immunantworten zur Antigenpräsentation. Ann Anat. 2001; 183 63-64 (Abstrakt)
- 11 Kuper C F, Koornstra P J, Hameleers D MH. et al . The role of nasopharyngeal lymphoid tissue. Immunol Today. 1992; 13 219-224
- 12 Bernstein J M. Mucosal immunology of the upper respiratory tract. Respiration. 1992; 59 3-13
- 13 Bachert C, Möller P. Die Tonsille als MALT (mucosa-associated lymphoid tissue) der Nasenschleimhaut. Laryngo-Rhino-Otol. 1990; 69 515-520
-
14 Russell M W, Kilian M, Lamm M E.
Biological activities of IgA. In: Ogra PL, Lamm ME, Bienenstock J, Mestecky J, Strober W, McGhee JR (Hrsg) Mucosal Immunology. San Diego, London, Boston; Academic Press 1999: 225-240 - 15 Childers N K, Bruce M G, McGhee J R. Molecular mechanisms of immunoglobulin A defense. Ann Rev Microbiol. 1989; 43 503-536
- 16 Stokes C R, Soothill J F, Turner M W. Immune exclusion is a function of IgA. Nature. 1975; 255 745-746
- 17 Funakoshi S, Dot T, Nakajima T, Suyama T, Tokuda M. Antimicrobial effect of human serum IgA. Microbiol Immunol. 1982; 26 227-239
- 18 Sun L K, Fung M S, Sun W N, Sun C R, Chang W I, Chang T W. Human IgA monoclonal antibodies specific for a major ragweed pollen antigen. Biotechnology N Y. 1995; 13 779-786
- 19 Nahm D H, Kim H Y, Park H S. Elevation of specific immunoglobulin A antibodies to both allergen and bacterial antigen in induced sputum from asthmatics. Eur Respir J. 1998; 12 540-545
- 20 Peebles-RS J, Liu M C, Adkinson-NF J, Lichtenstein L M, Hamilton R G. Ragweed-specific antibodies in bronchoalveolar lavage fluids and serum before and after segmental lung challenge: IgE and IgA associated with eosinophil degranulation. J Allergy Clin Immunol. 1998; 101 265-273
- 21 Abu-Ghazaleh R I, Fujisawa T, Mestecky J, Kyle R A, Gleich G J. IgA-induced eosinophil degranulation. J Immunol. 1989; 142 2393-2400
- 22 Schwarze J, Cieslewicz G, Joetham A. et al . Antigen-specific immunoglobulin-A prevents increased airway responsiveness and lung eosinophilia after airway challenge in sensitized mice. Am J Respir Crit Care Med. 1998; 158 519-525
- 23 Brandtzaeg P. Humoral Immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infection. JID. 1992; 165 S167-S176
- 24 Jeannin P, Lecoanet S, Delneste Y, Gauchat J F, Bonnefoy J Y. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol. 1998; 160 3555-3561
- 25 Devey M E, Wilson D V, Wheeler A W. The IgG subclass of antibodies to grass pollen allergens produced in hay fever patients during hyposensibilisation. Clin Allergy. 1976; 6 227-236
- 26 Van der Giessen M, Homann W L, Van Kernebeek G, Aalberse R C, Dieges P H. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy. Int Arch Allergy Appl Immunol. 1976; 50 625-640
- 27 Ohashi Y, Nakai Y, Kihara S, Nakagawa T, Miyamoto T. House dust mite-specific IgE, IgG1, and IgG4 antibodies in patients with perennial allergic rhinitis. Ann Otol Rhinol Laryngol. 1987; 96 434-437
- 28 Peebles-RS J, Liu M C, Lichtenstein L M, Hamilton R G. IgA, IgG and IgM quantification in bronchoalveolar lavage fluids from allergic rhinitis, allergic asthma, and normal subjects by monoclonal antibody-based immunoenzymetric assays. J Immunol Meth. 1995; 179 77-86
- 29 Aghayan U R, Ball T, Vrtala S, Schweiger C, Kraft D, Valenta R. Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens. J Allergy Clin Immunol. 2000; 105 803-813
- 30 Klimek L, Riechelmann H, Amedee R. Eosinophilic cationic protein in nasal secretions and blood serum in grass-pollen allergic rhinitis. Am J Rhinol. 1996; 10 319-323
- 31 Klimek L, Rasp G. Norm values for eosinophil cationic protein in nasal secretions: influence of specimen collection. Clin Exp Allergy. 1999; 29 367-374
- 32 Riechelmann H, Deutschle T, Friemel E, Gross H-J, Bachem M. Biological markers in nasal secretions. Eur Respir J. 2003; 21 600-605
- 33 Kramer M F, Ostertag P, Pfrogner E, Rasp G. Nasal Interleukin-5, Immunoglobulin E, Eosinophilic Cationic Protein, and soluble Intercellular Adhesion Molecule-1 in chronic sinustits, allergic rhinitis, and nasal polypsosis. Laryngoscope. 2000; 110 1056-1062
- 34 Kramer M F, Pfrogner E, Ostertag P, Rasp G. Nasal IL-16 and MIP-1 alpha in late phase allergic response. Allergy Asthma Proc. 2001; 22 127-132
- 35 Patriarca G, di Renzo V, Schiavino D. et al . Nasal secretion specific IgE in rhinitis patients. Allergol Immunopathol (Madr). 1990; 18 1-4
- 36 Kramer M F, Burow G, Pfrogner E, Rasp G. In-vitro diagnosis of chronic nasal inflammation. Clin Exp Allergy. 2004; in press
- 37 Matricardi P M, Nisini R, Biselli R, D'Amelio R. Evaluation of the overall degree of sensitization to airborne allergens by a single serologic test: implications for epidemiologic studies of allergy. J Allergy Clin Immunol. 1994; 93 68-79
- 38 Matricardi P M, Nisini R, Pizzolo J G, D'Amelio R. The use of Phadiatop in mass-screening programmes of inhalant allergies: advantages and limitations. Clin Exp Allergy. 1990; 20 151-155
- 39 Wever A M, Wever-Hess J, van Schayck C P, van Weel C. Evaluation of the Phadiatop test in an epidemiological study. Allergy. 1990; 45 92-97
- 40 Salkie M L. The Phadiatop test allows adequate screening for atopy with a marked reduction in cost. J Clin Lab Anal. 1991; 5 226-227
- 41 Kohl C, Debelic M. In vitro screening for inhalant allergy with multi SX 1 RAST (Phadiatop). Allergy. 1991; 46 245-250
- 42 Perry M, Whyte A. Immunology of the tonsils. Immunol Today. 1998; 19 414-421
- 43 Gebert A, Pabst R. M cells at locations outside the gut. Sem Immunology. 1999; 11 165-170
- 44 Bousquet J, Lockey R F, Malling H J. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy. 1998; 53 1-42
- 45 Bousquet J, van-Cauwenberge P, Khaltaev N, Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allerg Clin Immunol. 2001; 108 S147-S334
- 46 Ippoliti F, De Santis W, Volterrani A. et al . Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol. 2003; 14 216-221
- 47 Pajno G B, Morabito L, Barberio G, Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy. 2000; 55 842-849
- 48 Bagnasco M, Mariani G, Passalacqua G. et al . Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol. 1997; 100 122-129
- 49 Nair P NR, Schroeder H E. Retrograde access of antigens to the minor salivary glands in the monkey Macaca fascicularis. Arch Oral Biol. 1983; 28 145-152
-
50 McGhee J R, Czerkinsky C, Mestecky J.
Mucosal vaccines: an overview. In: Ogra PL, Lamm ME, Bienenstock J, Mestecky J, Strober W, McGhee JR (Hrsg) Mukosal Immunology. San Diego, London, Boston; Academic Press 1999: 741-758 - 51 Powe D G, Mason M T, Chester M. et al . Secretory IgA (sIgA) production is not increased in nasal mucosa after allergen challenge. Clin Exp Allergy,. submitted 2004;
- 52 Durham S R, Gould H J, Hamid Q A. Local IgE production in nasal allergy. Int Arch Allergy Immunol. 1997; 113 128-130
- 53 Smurthwaite L, Durham S R. Local IgG synthesis in allergic rhinitis and asthma. Curr Allergy Asthma Rep. 2002; 2 231-238
- 54 KleinJan A, Vinke J G, Severijnen L W, Fokkens W J. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J. 2000; 15 491-497
Dr. med. Matthias F. Kramer
Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde am Klinikum Großhadern, Ludwig-Maximilians-Universität München
Marchioninistraße 15 · 81377 München ·
eMail: Matthias. Kramer@med. uni-muenchen. de